InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Todisco Joseph, Chairman & CEO. Director active across 2 companies, notably Amneal Pharmaceuticals, Inc.. Aggregated, 9 filings have been logged. Total volume traded: €43k. The latest transaction was disclosed on 16 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€32,37910,000 shares@ €3.23790.0035% mcap100.0% of flow
Common Stock
SEC:0001213900-22-027450:0·
Ideal exit: 10 Feb 2023 (T+270)
0207,469 shares0
Common Stock
SEC:0001213900-22-025973:0·
4,442 shares
Class A Common Stock
SEC:0001209191-22-028164:0·
11,111 shares
Class A Common Stock
SEC:0001209191-22-016056:0·
29,684 shares
Class A Common Stock
SEC:0001209191-22-014150:0·
€5,4331,500 shares@ €3.62210.0001% mcap100.0% of flow
Class A Common Stock
SEC:0001209191-21-067956·
€5,4331,500 shares@ €3.62210.0001% mcap50.0% of flow
Class A Common Stock
SEC:0001209191-21-067956:0·
4,441 shares
Class A Common Stock
SEC:0001209191-21-031567·
4,441 shares
Class A Common Stock
SEC:0001209191-21-031567:0·
9 of 9 declarations
About Todisco Joseph
Joseph Todisco serves as Executive Vice President and Chief Executive Officer of Amneal Pharmaceuticals, Inc. and CorMedix Inc. In his roles, he leads the operations of both companies, setting the strategic vision and overseeing teams. Joseph has extensive experience in the pharmaceutical industry, contributing to growth and innovation.
